FDA Adverse Event Malfunction Summary report: N

AVALON US TRANSDUCER

MDR report key: 19419491 · Received May 29, 2024

Report

Report Number
9610816-2024-00288
Event Type
Malfunction
Date Received
May 29, 2024
Date of Event
December 27, 2023
Report Date
September 11, 2024
Manufacturer
PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH
Product Code
HGL
PMA / PMN Number
K140535
Removal / Correction Number
Z-2239-2024
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
BIOMEDICAL ENGINEER
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE INFORMATION AVAILABLE AND THE TESTING CONDUCTED, THE CAUSE OF THE REPORTED PROBLEM WAS A DESIGN DEFECT IN THE TRANSDUCER'S FIRMWARE (FW). PHILIPS INVESTIGATION DETERMINED THIS ISSUE IS CAUSED BY CHANGES IMPLEMENTED UNDER AN ENGINEERING CHANGE RELEASED MAY 25,2023. THESE CHANGES UPDATED THE ULTRASOUND T=TRANSDUCER WITH A NEW CENTRAL PROCESSING UNIT (CPU) BOARD AND FIRMWARE IN RESPONSE TO A SHORTAGE OF MULTIPLE COMPONENTS. DUE TO A CHIP SHORTAGE SITUATION, A HARDWARE (HW)/SOFTWARE (SW) DESIGN CHANGE WAS REQUIRED, WHICH INTRODUCED A PERFORMANCE ISSUE TO THE FETAL HEART RATE (FHR) MEASUREMENT OF WIRED ULTRASOUND (US) TRANSDUCERS. THE NEED FOR SUBTLE ADJUSTMENTS OF THE TRANSMIT/RECEIVE TIME WINDOWS IN US MEASUREMENTS UNEXPECTEDLY INTRODUCED INTERFERENCE WITH ADJACENT TRANSDUCERS (TWIN/TRIPLET USE CASES) BY GENERATING MEASURABLE ARTIFICIAL RHYTHMIC SIGNALS THAT CAN BE INTERPRETED AS ACTUAL PHYSIOLOGICAL SIGNALS (FETAL HEART BEATS). THIS INVESTIGATION DETERMINED THAT THE NEW FIRMWARE (453564254621-S-FW-01, REV L.01.04) WHICH IS DESIGNED FOR ALL AVALON TRANSDUCERS, SHOWS AN UNEXPECTED ISSUE FOR THE ULTRASOUND TRANSDUCER (867246). WHEN MONITORING MULTIPLES (TWINS OR TRIPLETS), THE WIRED AVALON ULTRASOUND TRANSDUCERS (PRODUCT NO. 867246) HAVE A TENDENCY TO PRODUCE AN ARTIFICIAL FETAL HEART RATE (FHR) INSTEAD OF FHR GAPS, MOSTLY AT APPROXIMATELY 180 BPM, IN SITUATIONS WHERE THE PHYSIOLOGICAL SIGNAL (ECHO FROM PULSATING FETAL HEART) IS ABSENT OR VERY WEAK. THE CUSTOMER WILL RECEIVE THE FIELD CHANGE ORDER UPDATE AT A FUTURE DATE. THE CUSTOMER HAS BEEN NOTIFIED OF THIS ISSUE AND THE FIRMWARE WILL BE UPDATED IN THE FUTURE. THE INVESTIGATION CONCLUDES THAT NO FURTHER ACTION IS REQUIRED AT THIS TIME. IF ADDITIONAL INFORMATION IS RECEIVED THE COMPLAINT FILE WILL BE REOPENED.

Additional Manufacturer Narrative · 0

PHILIPS IS IN THE PROCESS OF OBTAINING ADDITIONAL INFORMATION CONCERNING THIS EVENT AND THE COMPLAINT IS STILL UNDER INVESTIGATION. A FINAL REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETE.

Description of Event or Problem · 0

IT WAS REPORTED THAT A BEAT SEEMS TO JUMP TO 180 VERY INTERMITTENTLY. THE STAFF IS MONITORING TWINS AND SEES NO ISSUE WITH THE BABY. THE INITIAL INVESTIGATION FOCUSED ON THE PRODUCT HARDWARE AND A SOCKET CONNECTOR BLOCK WAS SENT TO THE CUSTOMER. THE DEVICE WAS IN USE ON A PATIENT AT THE TIME OF THE EVENT. THERE WAS NO ADVERSE EVENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1884057 AVALON US TRANSDUCER AVALON US TRANSDUCER HGL PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH 867246

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown